Medicine & Health

Researchers at Washington University School of Medicine have found that multidrug-resistant bacteria and bacterial spores can be killed by ultrashort-pulse lasers. The findings could lead to new ways to sterilize wounds and blood products without damaging human cells.

Researchers at Washington University are receiving one of 19 grant awards that will support data science research and training activities in Africa. The researchers will focus on developing new training programs in health data science in Rwanda.

People taking TNF inhibitors, a kind of immunosuppressive drug used to treat rheumatoid arthritis and other autoimmune conditions, produced a weaker and shorter-lived antibody response after two doses of Pfizer’s COVID-19 vaccine, according to a study from Washington University School of Medicine.

Daniel Kreisel, surgical director of lung transplantation at Washington University School of Medicine and Barnes-Jewish Hospital, is a principal investigator in a clinical trial funded with a $22 million grant from the National Institutes of Health (NIH). The trial aims to reduce lung transplant rejection.

The lab of Fuzhong Zhang at the McKelvey School of Engineering has used synthetic biology to bring together the best of spider silk and mussel foot protein in a biocompatible adhesive.

Washington University School of Medicine researchers, studying mice, have developed a method of stem cell transplantation that does not require radiation or chemotherapy. The study opens the door to safer stem cell transplantation.

Computer scientist Chenyang Lu at the McKelvey School of Engineering has been building bridges with doctors to improve patients’ health outcomes using engineering.

Researchers at Washington University School of Medicine have found that the drug fluvoxamine has been shown, in a pair of studies conducted on two continents, to be an effective treatment for people sick with COVID-19.

A new study led by researchers at Washington University School of Medicine suggests that a widely used heart failure drug named sacubitril/valsartan is no better than valsartan alone in patients with severe heart failure.

P. Roy Vagelos, MD, and his wife, Diana Vagelos, are providing $15 million to support the university’s Division of Biology & Biomedical Sciences. The gift will fund undergraduate and graduate work in the life sciences. The couple made the gift to honor former Chancellor William H. Danforth, MD, who died last year.